openPR Logo
Press release

Anemia Drugs Market 2018 Grow at CAGR of 8.4% to Reach USD 34.7 Billion | By Unique Anemia Type Iron Deficiency Anemia, Sickle Cell Anemia and More

08-22-2018 01:31 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Anemia Drugs Market

Anemia Drugs Market

Market Research Future Published a Prime research Report on “Global Anemia Drugs Market Research Report - Forecast to 2022” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2022

Global Anemia Drugs Market - Segments

Global anemia drugs market has been segmented on the basis of anemia type which comprises iron deficiency anemia, sickle cell anemia, aplastic anemia, hemolytic anemia pernicious anemia and others. On the basis of route of administration; market is segmented into oral and injectable. On the basis of gender; market is segmented into male and female. On the basis of product type; market is segmented into biologics and non-biologics. On the basis of end users; market is segmented into hospitals, self-administered and others.

Premium Sample Report Available @ https://www.marketresearchfuture.com/sample_request/2499

Global Anemia Drugs Market - Market Scenario

Anemia is a set of conditions characterized by weakness, shortness of breath and a general tiredness due to a decrease in the total amount of red blood cells (RBCs) or hemoglobin in the blood. The lowered hemoglobin results in a lowered ability of the blood to carry oxygen.

The market constraints are poor absorption of drugs especially intravenous iron and the side effects associated with the treatment. Better nutrition due to rising per capita income is also a market limiting factor for anemic drugs.

The global market for Anemia Drugs is expected to be around US$21.4 billion and is expected to grow at a CAGR of 8.4% to reach US$34.7 billion by the end of forecast period.

Global Anemia Drugs Market - Key Players

Some of the key players in this market are: Amgen Inc., GlaxoSmithKline plc, Bluebird bio, Biocon, GlycoMimetics Inc., Regen biopharma Inc., Bayer AG, Acceleron Pharma, Eli Lilly and company and others.

Global Anemia Drugs Market - Competitive Analysis

In April-2017, Amgen Inc. expanded their commercial collaboration with Novartis for erenumab, which is being investigated for the prevention of migraine. This expanded commercial collaboration was built on a global neuroscience collaboration in Alzheimer's disease and migraine established in 2015 between Novartis and Amgen. This expanded collaboration leveraged Novartis' strong and established presence in neuroscience to more effectively reach people with migraine.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/anemia-drugs-market-2499 

In December-2015, GlaxoSmithKline plc. announced that its global HIV business, ViiV Healthcare, has reached two separate agreements with Bristol-Myers Squibb, to acquire its late-stage HIV R&D assets; and to acquire Bristol-Myers Squibb’s portfolio of preclinical and discovery stage HIV research assets.

In October-2016, Elanco U.S., Inc., a subsidiary of Eli Lilly and Company acquired Boehringer Ingelheim Vetmedica, Inc.'s (BIVI) U.S. feline, canine and rabies vaccines portfolio - as well as a fully integrated manufacturing and R&D site - for USD 885 million, including the estimated cost of acquired inventory.

Global Anemia Drugs Market - Regional Analysis

On the regional backgrounds the Americas leads the global market for anemia drugs owing to huge patient population, increasing healthcare expenditures and presence of the developed economies like U.S. and Canada within the region. Following, the same trends Europe is second in the market. The Asia Pacific region is the fastest growing region due to the developing economies like India and China. Middle East and Africa have the least market share, especially due to the presence of poor economies within the African region. Moreover, stringent government policies within the region are restraining the market growth within the region. On the hand, Middle East leads the regional market due to the presence of developed economies like Kuwait, Qatar, and others within the region and rising healthcare expenses.

Table Of Contents

1 Introduction

2 Research Methodology

3 Market Dynamics

4 Market Factor Analysis

5 Global Anemia Drugs Market, By Anemia Type

6 Global Anemia Drugs Market, By Route Of Administration

7 Global Anemia Drugs Market, By Product Type

8 Global Anemia Drugs Market, By End User

9 Global Anemia Drugs Market, By Regions

10 Company Landscape

11 Company Profile

12 Others

13 Appendix

Major TOC Continued…!

Get Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/2499

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anemia Drugs Market 2018 Grow at CAGR of 8.4% to Reach USD 34.7 Billion | By Unique Anemia Type Iron Deficiency Anemia, Sickle Cell Anemia and More here

News-ID: 1194016 • Views:

More Releases from Market Research Future

Virtual Reality in Gaming Market Size Worth USD 17.1 Billion by 2032 | CAGR 4.70%
Virtual Reality in Gaming Market Size Worth USD 17.1 Billion by 2032 | CAGR 4.70 …
The Virtual Reality (VR) in Gaming Market is experiencing steady growth, driven by advancements in VR hardware, immersive gaming experiences, and increasing consumer demand for interactive entertainment. The market was valued at USD 11.31 billion in 2023 and is projected to expand from USD 11.84 billion in 2024 to USD 17.1 billion by 2032, registering a compound annual growth rate (CAGR) of 4.70% during the forecast period (2024-2032). Key Companies in
Future of Ethernet Switch Market: USD 11.2 Billion Size Forecast by 2032
Future of Ethernet Switch Market: USD 11.2 Billion Size Forecast by 2032
The Ethernet Switch Market is experiencing steady growth, driven by the rapid expansion of data centers, rising internet traffic, and the increasing adoption of cloud computing and enterprise networking solutions. The market was valued at USD 6.4 billion in 2023 and is projected to grow from USD 7.11 billion in 2024 to USD 11.2 billion by 2032, registering a compound annual growth rate (CAGR) of 5.50% during the forecast period
Rising Demand for Advanced Testing Solutions Driving Digital Oscilloscope Market to USD 6.12 Billion by 2032
Rising Demand for Advanced Testing Solutions Driving Digital Oscilloscope Market …
The Digital Oscilloscope Market is witnessing robust growth, driven by the rising demand for advanced testing equipment, innovations in signal analysis technologies, and the growing adoption of digital devices across industries. The market was valued at USD 3.67 billion in 2022 and is projected to expand to USD 6.12 billion by 2032, reflecting a compound annual growth rate (CAGR) of 5.24% during the forecast period (2024-2032). Key Companies in Digital Oscilloscope
Super Capacitors Market Set for 18.16% CAGR, Reaching USD 2.50 Billion by 2032
Super Capacitors Market Set for 18.16% CAGR, Reaching USD 2.50 Billion by 2032
The Global Super Capacitors Market is witnessing significant growth, driven by rising demand for energy-efficient storage solutions, rapid adoption of electric vehicles (EVs), and advancements in renewable energy systems. The market was valued at USD 0.544 billion in 2023 and is projected to reach USD 2.501 billion by 2032, growing at a compound annual growth rate (CAGR) of 18.16% during the forecast period (2024-2032). Key Companies in Super Capacitors Market include • Maxwell

All 5 Releases


More Releases for Anemia

Rising Cancer And Anemia Cases Propel Growth In Chemotherapy-Induced Anemia Mark …
The Chemotherapy-Induced Anemia Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Chemotherapy-Induced Anemia Market Size During the Forecast Period? The Chemotherapy-Induced Anemia Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This
Iron Deficiency Anemia Market Analysis 2034 | Iron Deficiency Anemia Therapies, …
As per DelveInsight, the Iron Deficiency Anemia Market is anticipated to grow immensely in the coming years owing to the launch of upcoming therapies and the increase in the incident population of Iron Deficiency Anemia in the 7MM. DelveInsight's "Iron Deficiency Anemia Market Insights, Epidemiology, and Market Forecast 2034 [https://www.delveinsight.com/report-store/iron-deficiency-anemia-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Iron Deficiency Anemia market size,
Aplastic Anemia Treatment Market - Shaping the Future of Aplastic Anemia Health: …
Newark, New Castle, USA: The "Aplastic Anemia Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Aplastic Anemia Treatment Market: https://www.growthplusreports.com/report/aplastic-anemia-treatment-market/8435 This latest report researches the industry structure,
Anemia in Chronic Kidney Disease (Renal Anemia) - Industry Analysis, Trends, and …
Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Anemia in Chronic Kidney Disease Pipeline Review, H1 2017” to its report offerings. The report provides an overview of the Anemia in Chronic Kidney Disease (Renal Anemia) (Hematological Disorders) pipeline landscape. Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1196648 Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2017,
Global Anemia in Chronic Kidney Disease (Renal Anemia) Clinical Trials Market Re …
Market Research Hub's clinical trial report, Global Anemia in Chronic Kidney Disease (Renal Anemia) Clinical Trials Review, H1, 2017, provides an overview of Anemia in Chronic Kidney Disease (Renal Anemia) clinical trials scenario. This report provides top line data relating to the clinical trials on Anemia in Chronic Kidney Disease (Renal Anemia). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Request
Current research on Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline R …
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anemia in Chronic Kidney Disease Pipeline Review, H2 2016, provides an overview of the Anemia in Chronic Kidney Disease (Hematological Disorders) pipeline landscape. Renal anemia is a disease in which the patient has an unusually low count of red blood cells. Renal is a term that means of the kidneys, so anemia is often associated with kidney disease. This type of